In a filing, Ingersoll-Rand Inc revealed its insider Reynal Vicente unloaded Company’s shares for reported $3.21 million on May 20 ’25. In the deal valued at $83.03 per share,38,657 shares were sold. As a result of this transaction, Reynal Vicente now holds 193,186 shares worth roughly $17.2 million.
Then, Reynal Vicente bought 38,657 shares, generating $3,209,772 in total proceeds.
Before that, Hepding Elizabeth Meloy sold 3,500 shares. Ingersoll-Rand Inc shares valued at $293,230 were divested by the insider at a price of $83.78 per share. As a result of the transaction, Hepding Elizabeth Meloy now holds 10,986 shares, worth roughly $0.98 million.
Stifel downgraded its Ingersoll-Rand Inc [IR] rating to a Hold from a a Buy in a research note published on November 18, 2024; the price target was decreased to $107 from $112. Morgan Stanley began covering IR with “an Equal-weight” recommendation on September 06, 2024.
Price Performance Review of IR
On Friday, Ingersoll-Rand Inc [NYSE:IR] saw its stock jump 0.37% to $89.02. Over the last five days, the stock has gained 2.35%. Ingersoll-Rand Inc shares have fallen nearly -2.95% since the year began. Nevertheless, the stocks have fallen -1.59% over the past one year. While a 52-week high of $106.03 was reached on 01/31/25, a 52-week low of $65.61 was recorded on 04/08/25.
Levels Of Support And Resistance For IR Stock
The 24-hour chart illustrates a support level at 88.10, which if violated will result in even more drops to 87.18. On the upside, there is a resistance level at 89.55. A further resistance level may holdings at 90.07.
How much short interest is there in Ingersoll-Rand Inc?
A steep rise in short interest was recorded in Ingersoll-Rand Inc stocks on 2025-06-13, growing by 1.88 million shares to a total of 12.12 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 10.23 million shares. There was a rise of 15.54%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on March 12, 2024 when Exane BNP Paribas began covering the stock and recommended ‘”a Neutral”‘ rating along with a $92 price target.